154 related articles for article (PubMed ID: 7788882)
1. Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease.
Mueller HW; Haught CA; McNatt JM; Cui K; Gaskell SJ; Johnston DA; Willerson JT
Circ Res; 1995 Jul; 77(1):54-63. PubMed ID: 7788882
[TBL] [Abstract][Full Text] [Related]
2. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
3. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
Yao SK; Benedict CR; Rosolowsky M; McNatt J; Falinska B; Campbell WB; Buja LM; Willerson JT
J Mol Cell Cardiol; 1991 Apr; 23(4):473-82. PubMed ID: 1942081
[TBL] [Abstract][Full Text] [Related]
4. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
Apprill P; Schmitz JM; Campbell WB; Tilton G; Ashton J; Raheja S; Buja LM; Willerson JT
Circulation; 1985 Aug; 72(2):397-405. PubMed ID: 2988822
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel scintillation proximity radioimmunoassay for platelet-activating factor measurement: comparison with bioassay and GC/MS techniques.
Sugatani J; Lee DY; Hughes KT; Saito K
Life Sci; 1990; 46(20):1443-50. PubMed ID: 2111868
[TBL] [Abstract][Full Text] [Related]
6. Constriction of canine coronary arteries by platelet activating factor after brief ischemia.
Kim YD; Danchak RM; Heim KF; Lees DE; Myers AK
Prostaglandins; 1993 Sep; 46(3):269-76. PubMed ID: 8234834
[TBL] [Abstract][Full Text] [Related]
7. Endothelium from diverse vascular sources synthesizes platelet-activating factor.
Whatley RE; Zimmerman GA; McIntyre TM; Prescott SM
Arteriosclerosis; 1988; 8(3):321-31. PubMed ID: 3130833
[TBL] [Abstract][Full Text] [Related]
8. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells.
Schlondorff D; Goldwasser P; Neuwirth R; Satriano JA; Clay KL
Am J Physiol; 1986 Jun; 250(6 Pt 2):F1123-7. PubMed ID: 3087218
[TBL] [Abstract][Full Text] [Related]
9. Structural heterogeneity of platelet-activating factor produced by murine preimplantation embryos.
Ammit AJ; Wells XE; O'Neill C
Hum Reprod; 1992 Jul; 7(6):865-70. PubMed ID: 1500487
[TBL] [Abstract][Full Text] [Related]
10. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
Tiberghien C; Laurent L; Junier MP; Dray F
J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
[TBL] [Abstract][Full Text] [Related]
11. Biphasic effects of platelet-activating factor on coronary blood flow in anesthetized dog.
Mehta J; Wargovich T; Nichols WW
Prostaglandins Leukot Med; 1986 Jan; 21(1):87-95. PubMed ID: 3456620
[TBL] [Abstract][Full Text] [Related]
12. High performance liquid chromatography of platelet-activating factors.
Jackson EM; Mott GE; Hoppens C; McManus LM; Weintraub ST; Ludwig JC; Pinckard RN
J Lipid Res; 1984 Jul; 25(7):753-7. PubMed ID: 6481248
[TBL] [Abstract][Full Text] [Related]
13. Effects of coronary angioplasty on plasma platelet-activating factor in man.
Eldar M; Lysko PG; Schulhoff N; Gagnon RC; Feuerstein G; Shani J
J Lipid Mediat; 1992 Sep; 5(3):313-9. PubMed ID: 1467464
[TBL] [Abstract][Full Text] [Related]
14. Production of platelet-activating factor in photocoagulated retinas.
Dharma S; Bazan HE; Peyman GA; Atef MS
Curr Eye Res; 1991 Nov; 10(11):1031-5. PubMed ID: 1782801
[TBL] [Abstract][Full Text] [Related]
15. Compounds biologically similar to platelet activating factor are present in stored blood components.
Silliman CC; Johnson CA; Clay KL; Thurman GW; Ambruso DR
Lipids; 1993 May; 28(5):415-8. PubMed ID: 8316049
[TBL] [Abstract][Full Text] [Related]
16. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
17. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks.
Sarchielli P; Alberti A; Coppola F; Baldi A; Gallai B; Floridi A; Floridi A; Capocchi G; Gallai V
Cephalalgia; 2004 Aug; 24(8):623-30. PubMed ID: 15265050
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
20. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization.
Balazy M; Braquet P; Bazan NG
Anal Biochem; 1991 Jul; 196(1):1-10. PubMed ID: 1888023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
